Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1995 1
1996 2
1998 2
2000 2
2001 1
2006 1
2007 1
2008 1
2009 1
2010 2
2011 1
2012 2
2015 1
2017 1
2019 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Risk factors for health impairments in children after hospitalization for acute COVID-19 or MIS-C.
Maddux AB, Young CC, Kucukak S, Zambrano LD, Newhams MM, Rollins CK, Halasa NB, Gertz SJ, Mack EH, Schwartz S, Kong M, Loftis LL, Irby K, Rowan CM, Tarquinio KM, Zinter MS, Crandall H, Cvijanovich NZ, Schuster JE, Fitzgerald JC, Staat MA, Hobbs CV, Nofziger RA, Shein S, Flori H, Cullimore ML, Chatani BM, Levy ER, Typpo KV, Hume JR, Campbell AP, Randolph AG; Overcoming COVID-19 Investigators. Maddux AB, et al. Front Pediatr. 2023 Oct 18;11:1260372. doi: 10.3389/fped.2023.1260372. eCollection 2023. Front Pediatr. 2023. PMID: 37920792 Free PMC article.
[Memorandum III, Part 3: Quality of Care and Patient Safety Research Methods].
Geraedts M, Drösler SE, Döbler K, Eberlein-Gonska M, Heller G, Kuske S, Manser T, Sens B, Stausberg J, Schrappe M. Geraedts M, et al. Among authors: sens b. Gesundheitswesen. 2017 Oct;79(10):e95-e124. doi: 10.1055/s-0043-112431. Epub 2017 Sep 28. Gesundheitswesen. 2017. PMID: 28958111 Free article. German.
Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease.
Bank U, Heimburg A, Helmuth M, Stefin S, Lendeckel U, Reinhold D, Faust J, Fuchs P, Sens B, Neubert K, Täger M, Ansorge S. Bank U, et al. Among authors: sens b. Int Immunopharmacol. 2006 Dec 20;6(13-14):1925-34. doi: 10.1016/j.intimp.2006.09.014. Epub 2006 Oct 17. Int Immunopharmacol. 2006. PMID: 17161345
23 results